We are excited to have a recent study published that benchmarks discovery compounds that turn off the NF-kB pathway in cancer. This was innovative study because
We are excited to have a recent study published that benchmarks discovery compounds that turn off the NF-kB pathway in cancer. This was innovative study because
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute